23 results
424B3
PYXS
Pyxis Oncology Inc
30 Jun 23
Prospectus supplement
4:05pm
materials from third-party suppliers and potential exposure to supply chain issues impacting delivery dates, quality, quantity and pricing of raw … perform according to the terms of the agreements between Apexigen and them;
the possible failure of Apexigen’s third-party manufacturer to procure raw
S-4/A
6wfjr6mtwf4abp2v41
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
1t08l1 tgt0qrn0x40
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
rj7j31m 0r5m
24 May 23
Business combination disclosure
7:05am
425
g7ndl1ktt1vjyi
24 May 23
Business combination disclosure
7:03am
8-K
EX-2.1
iyd75s2 c9guk
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
10-K
sxduc7eua57af8
29 Mar 22
Annual report
7:36am
10-Q
5ii 53z47sp
15 Nov 21
Quarterly report
7:54am
424B4
8kjmzsym
8 Oct 21
Prospectus supplement with pricing info
5:00pm
S-1
0jo bpusjlqq7vc2h
17 Sep 21
IPO registration
5:00pm